Brief: Journey Medical Reports Q1 Loss Of $0.57 Per Share
May 22 (Reuters) - Journey Medical Corp DERM.O :
* JOURNEY MEDICAL CORP-QTRLY TOTAL NET PRODUCT REVENUES WERE
$12.2
MILLION VERSUS NET PRODUCT REVENUES OF $20.8 MILLION FOR Q1 OF
2022
* JOURNEY MEDICAL CORP-QTRLY NET LOSS WAS $10.1 MILLION, OR
$0.57
PER SHARE BASIC AND DILUTED
Source text for Eikon: ID:nGNX1xSW2B
Further company coverage: DERM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi